Quince Therapeutics regains Nasdaq listing compliance after equity rises to $15.67 million

Quince Therapeutics, Inc.

Quince Therapeutics, Inc.

QNCX

0.00
  • Quince Therapeutics regained compliance with Nasdaq Global Market continued listing standards, closing a prior deficiency tied to the minimum market value of listed securities requirement.
  • Nasdaq had issued a notice on March 17, 2026, citing failure to maintain a $50 million minimum market value of listed securities over 30 consecutive business days under Listing Rule 5450(b)(2)(A).
  • A May 20, 2026 letter from Nasdaq said the company now meets Listing Rule 5450(b)(1)(A) based on stockholders’ equity of $15.67 million reported in its quarterly filing for the period ended March 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quince Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-234858), on May 21, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.